News & Updates

Adjuvant palbociclib in combination with endocrine therapy (ET) does not improve invasive disease-free survival (iDFS) or secondary endpoints vs ET alone in patients with hormone receptor–positive, HER2-negative early breast cancer, final results of the phase III PALLAS trial have shown.

In breast cancer patients treated with anthracycline-containing regimens, reducing the first-day dose of dexamethasone does not yield significant gastrointestinal benefit and is not recommended for nausea management, a recent study has found.

A diet with increased consumption of fruits, vegetables, breakfast cereals, and dietary fibre, as well as low intake of red and processed meat, appears to reduce the risk of lung cancer, suggests a study.

Abstinence from alcoholic drinks reduces the risk of hepatocellular carcinoma (HCC) in patients with alcohol-related liver cirrhosis, but not in those with a history of decompensated disease, reveals a study.